Biology of Infectious Diseases Training Program

传染病生物学培训计划

基本信息

项目摘要

DESCRIPTION (provided by applicant): This is a second revised application for competitive renewal for the UCSF Biology of Infectious Diseases Training Program to train physician-scientists for productive careers in fundamental scientific investigations of infectious diseases. Infectious diseases are the third most common cause of death in the United States, despite widespread availability of antibiotics, vaccines, and high standards of public health. Worldwide, infectious diseases are the leading cause of death. Emergence of new pathogens, re-emergence of old ones, increasing resistance to antimicrobials, and pressures of globalization have broken down barriers and contributed to the spread of infectious diseases. Strategies to contain and control the spread of infectious diseases increasingly will rely on strong epidemiologic and population-based approaches and advances in basic research resulting from applications of discoveries in the fields of genomics, microbial pathogenesis, and immunology. The UCSF Biology of Infectious Diseases Training Program, which is modeled according to Infectious Diseases Society of America guidelines and recommendations, features two training tracks, a Basic Investigator Track and a Clinical Investigator Track. These two tracks provide the structural framework for acquisition and translation of research tools, skills, and experiences and for cultivating the scientific creativity that are essential for a successful research-oriented career. The two-track structure also affords the opportunity for interdisciplinary exchange and interactions. The program benefits from a well-established didactic infrastructure and an interactive faculty who direct research programs offering a rich and diversified training environment of exceptional depth and quality. Training is focused on MD and MD-PhD applicants, but PhD post-doctoral candidates are also accepted. In existence for only five years, the program has had considerable success in transitioning trainees to independent sources of research funding and starting them on promising career trajectories. This revised application features an innovative plan to recruit underrepresented minority trainees into the program; viewed as the weakness of the previous version, we believe this plan represents a major strength of the revised proposal. Relevance: The proposed training program is highly relevant to public health, a major concern of which is the control of infectious diseases. We will be training the next generation of medical scientists who will have responsibility for public health and devising strategies to contain the threats posed by infectious agents, scientists who will conduct the studies needed to identify new agents, and those who will discover approaches and therapies to overcome them.
描述(由申请人提供):这是UCSF传染病生物学培训计划的竞争性更新的第二次修订申请,旨在培养传染病基础科学调查的生产性职业的医生科学家。传染病是美国第三大常见的死亡原因,尽管抗生素,疫苗和高标准的公共卫生广泛可用。在世界范围内,传染病是导致死亡的主要原因。新病原体的出现、旧病原体的重新出现、对抗菌素的耐药性增加以及全球化的压力打破了障碍,助长了传染病的传播。遏制和控制传染病传播的策略将越来越多地依赖于强有力的流行病学和基于人群的方法以及基因组学、微生物发病机制和免疫学领域发现的应用所带来的基础研究进展。加州大学旧金山分校传染病生物学培训计划是根据美国传染病学会指南和建议建模的,具有两个培训轨道:基础研究者轨道和临床研究者轨道。这两条轨道提供了结构框架,用于获取和翻译研究工具,技能和经验,并培养科学创造力,这对成功的研究型职业生涯至关重要。双轨结构也提供了跨学科交流和互动的机会。该计划受益于完善的教学基础设施和互动教师,他们指导研究计划,提供丰富多样的培训环境,具有卓越的深度和质量。培训重点是MD和MD-PhD申请人,但也接受博士博士后候选人。该计划仅存在五年,在将学员转变为独立的研究资金来源并开始他们有前途的职业轨迹方面取得了相当大的成功。这个修订后的应用程序具有创新的计划,以招募代表性不足的少数民族学员进入该计划;被视为以前版本的弱点,我们认为这个计划代表了修订后的建议的主要优势。相关性:拟议的培训方案与公共卫生高度相关,公共卫生的一个主要关切是传染病的控制。我们将培训下一代医学科学家,他们将负责公共卫生和制定战略,以遏制传染性病原体构成的威胁,科学家将进行识别新病原体所需的研究,以及那些将发现克服它们的方法和疗法的科学家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Henry F HENRY CHAMBERS其他文献

Henry F HENRY CHAMBERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Henry F HENRY CHAMBERS', 18)}}的其他基金

Novel Mechanisms of Beta-lactam Resistance in Staph Aureus
金黄色葡萄球菌β-内酰胺耐药的新机制
  • 批准号:
    8586251
  • 财政年份:
    2012
  • 资助金额:
    $ 20.71万
  • 项目类别:
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus
金黄色葡萄球菌β-内酰胺耐药的新机制
  • 批准号:
    8776911
  • 财政年份:
    2012
  • 资助金额:
    $ 20.71万
  • 项目类别:
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus
金黄色葡萄球菌β-内酰胺耐药的新机制
  • 批准号:
    8455851
  • 财政年份:
    2012
  • 资助金额:
    $ 20.71万
  • 项目类别:
Genetic Basis of Virulence of Community MRSA Clone USA300
社区 MRSA 克隆 ​​USA300 毒力的遗传基础
  • 批准号:
    7591811
  • 财政年份:
    2008
  • 资助金额:
    $ 20.71万
  • 项目类别:
Genetic Basis of Virulence of Community MRSA Clone USA300
社区 MRSA 克隆 ​​USA300 毒力的遗传基础
  • 批准号:
    7784570
  • 财政年份:
    2008
  • 资助金额:
    $ 20.71万
  • 项目类别:
Genetic Basis of Virulence of Community MRSA Clone USA300
社区 MRSA 克隆 ​​USA300 毒力的遗传基础
  • 批准号:
    7461989
  • 财政年份:
    2008
  • 资助金额:
    $ 20.71万
  • 项目类别:
Daptomycin therapy for serious staphylococcus aureus infection
达托霉素治疗严重金黄色葡萄球菌感染
  • 批准号:
    7044948
  • 财政年份:
    2003
  • 资助金额:
    $ 20.71万
  • 项目类别:
Gordon Research Conference on Staphylococcal Diseases
戈登葡萄球菌疾病研究会议
  • 批准号:
    6413328
  • 财政年份:
    2001
  • 资助金额:
    $ 20.71万
  • 项目类别:
PENICILLIN INTERACTIVE PROTEINS OF STAPHYLOCOCCUS AUREUS
金黄色葡萄球菌的青霉素相互作用蛋白
  • 批准号:
    6349926
  • 财政年份:
    2000
  • 资助金额:
    $ 20.71万
  • 项目类别:
Biology of Infectious Diseases Training Program
传染病生物学培训计划
  • 批准号:
    8512640
  • 财政年份:
    2000
  • 资助金额:
    $ 20.71万
  • 项目类别:

相似海外基金

Develop a programme to support the prevention of Non-Communicable Diseases (NCDs) in the Republic of Kenya.
制定一项计划,支持肯尼亚共和国预防非传染性疾病 (NCD)。
  • 批准号:
    23K09892
  • 财政年份:
    2023
  • 资助金额:
    $ 20.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Communicable Diseases
非传染性疾病
  • 批准号:
    MC_UU_00033/3
  • 财政年份:
    2023
  • 资助金额:
    $ 20.71万
  • 项目类别:
    Intramural
Research Training in Global Non-Communicable Diseases
全球非传染性疾病研究培训
  • 批准号:
    10554719
  • 财政年份:
    2023
  • 资助金额:
    $ 20.71万
  • 项目类别:
Usefulness of metabolite biomarker as a common pathway for the prevention of non-communicable diseases and frailty
代谢生物标志物作为预防非传染性疾病和虚弱的常见途径的有用性
  • 批准号:
    23H00452
  • 财政年份:
    2023
  • 资助金额:
    $ 20.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Strengthening Research Capacity in Innovative Global Health Technologies for Non-Communicable Diseases in Uganda
加强乌干达非传染性疾病创新全球卫生技术的研究能力
  • 批准号:
    10469877
  • 财政年份:
    2022
  • 资助金额:
    $ 20.71万
  • 项目类别:
Occupational disparities in survival from cancer and non-communicable diseases
癌症和非传染性疾病生存率的职业差异
  • 批准号:
    22K17401
  • 财政年份:
    2022
  • 资助金额:
    $ 20.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Building capacity for Implementation Science research in Non-Communicable Diseases (BImS-NCDs)
非传染性疾病(BImS-NCD)实施科学研究的能力建设
  • 批准号:
    10594552
  • 财政年份:
    2022
  • 资助金额:
    $ 20.71万
  • 项目类别:
Building capacity for Implementation Science research in Non-Communicable Diseases (BImS-NCDs)
非传染性疾病(BImS-NCD)实施科学研究的能力建设
  • 批准号:
    10469788
  • 财政年份:
    2022
  • 资助金额:
    $ 20.71万
  • 项目类别:
United States-Zambia Addressing Risk Factors for Non-Communicable Diseases (US-Zambia Risk NCD)
美国-赞比亚解决非传染性疾病的风险因素(美国-赞比亚风险非传染性疾病)
  • 批准号:
    10462351
  • 财政年份:
    2022
  • 资助金额:
    $ 20.71万
  • 项目类别:
Development of a comprehensive self-care system utilizing big data/AI to cure non-communicable diseases and validation of its effectiveness
开发利用大数据/人工智能治疗非传染性疾病的综合自我护理系统并验证其有效性
  • 批准号:
    22H03529
  • 财政年份:
    2022
  • 资助金额:
    $ 20.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了